Shares of Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP – Get Free Report) hit a new 52-week high during trading on Wednesday . The stock traded as high as $0.49 and last traded at $0.49, with a volume of 3890237 shares changing hands. The stock had previously closed at $0.44.
Elite Pharmaceuticals Price Performance
The company has a market capitalization of $518.11 million, a P/E ratio of 44.06 and a beta of 0.19. The business’s 50-day moving average is $0.32 and its two-hundred day moving average is $0.22. The company has a quick ratio of 2.09, a current ratio of 3.08 and a debt-to-equity ratio of 0.08.
Elite Pharmaceuticals Company Profile
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
See Also
- Five stocks we like better than Elite Pharmaceuticals
- How to Invest in Biotech Stocks
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- Stock Analyst Ratings and Canadian Analyst Ratings
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Best Stocks Under $5.00
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
